Tania Mariel Godoy Reyes

Innovation Manager at IDM (Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico), a joint research institute of Universitat de València and Universitat Politècnica de València.

IDM is a multidisciplinary research center combining chemistry, pharmacy and electronic engineering, with two core lines in health innovation: precision diagnostics & sensing, and advanced therapies & drug delivery control.

Our core technological capabilities include: stimuli-responsive mesoporous nanomaterials for controlled drug/gene delivery; NGS and digital PCR for liquid biopsy and biomarker analysis; optical, electrochemical and label-free holographic biosensors for real-time pathogen and biomarker detection; PK/PD physiological modeling; and advanced 3D/organoid disease models.

IDM holds +75 patents, has run 120+ direct contracts with companies (including Pfizer, L'Oréal, Cinfa, Kern Pharma), has generated 4 active spin-offs, and is part of CIBER-BBN/NANBIOSIS, with joint research units at Hospital La Fe and the Príncipe Felipe Research Center.

We are open to joining or supporting consortia for the Eureka Biotech Call 2026, particularly in diagnostics, biosensing, nanomedicine and drug delivery.